MRI‐based score to predict surgical difficulty in patients with rectal cancer. BJS 2018; 105: 140-146.
Published: 31st October 2017
Authors: L. Escal, S. Nougaret, B. Guiu, M. M. Bertrand, H. de Forges, R. Tetreau et al.
Rectal cancer surgery is technically challenging and depends on many factors. This study evaluated the ability of clinical and anatomical factors to predict surgical difficulty in total mesorectal excision.
Consecutive patients who underwent total mesorectal excision for locally advanced rectal cancer in a laparoscopic, robotic or open procedure after neoadjuvant treatment, between 2005 and 2014, were included in this retrospective study. Preoperative clinical and MRI data were studied to develop a surgical difficulty grade.
In total, 164 patients with a median age of 61 (range 26–86) years were considered to be at low risk (143, 87·2 per cent) or high risk (21, 12·8 per cent) of surgical difficulty. In multivariable analysis, BMI at least 30 kg/m2 (
This simple morphometric score may assist surgical decision‐making and comparative study by defining operative difficulty before surgery.Read more
You may also be interested in
Authors: E. J. Ryan, E. M. Creagh
Effect of Akt activation and experimental pharmacological inhibition on responses to neoadjuvant chemoradiotherapy in rectal cancer. BJS 2018; 105: e192-e203.
Authors: F. C. Koyama, C. M. Lopes Ramos, F. Ledesma, V. A. F. Alves, J. M. Fernandes, B. B. Vailati et al.
Notes: Molecular enhancement of treatment
Clinicopathological, genomic and immunological factors in colorectal cancer prognosis. BJS 2018; 105: e99-e109.
Authors: K. M. Marks, N. P. West, E. Morris, P. Quirke
Notes: Defines modern practice
Gut microbiome influences on anastomotic leak and recurrence rates following colorectal cancer surgery. BJS 2018; 105: e131-e141.
Authors: S. Gaines, C. Shao, N. Hyman, J. C. Alverdy
Notes: A neglected frontier
Circulating tumour cells and DNA as liquid biopsies in gastrointestinal cancer. BJS 2018; 105: e110-e120.
Authors: O. Nordgård, K. Tjensvoll, B. Gilje, K. Søreide
Notes: The inner space frontier
Histopathological and molecular classification of colorectal cancer and corresponding peritoneal metastases. BJS 2018; 105: e204-e211.
Authors: I. Ubink, W. J. van Eden, P. Snaebjornsson, N. F. M. Kok, J. van Kuik, W. M. U. van Grevenstein et al.
Notes: Mesenchymal subtype predominates
Preliminary results of a cohort study of induction chemotherapy‐based treatment for locally recurrent rectal cancer.
Authors: D. M. G. I. van Zoggel, S. J. Bosman, M. Kusters, G. A. P. Nieuwenhuijzen, J. S. Cnossen, G. J. Creemers et al.
Notes: Promising responses
Quality of life in a randomized trial of early closure of temporary ileostomy after rectal resection for cancer (EASY trial). BJS 2018; 105: 244-251.
Authors: J. Park, A. K. Danielsen, E. Angenete, D. Bock, A. C. Marinez, E. Haglind et al.
Notes: No different after early ileostomy closure
Growth rates of pulmonary metastases after liver transplantation for unresectable colorectal liver metastases. BJS 2018; 105: 295-301.
Authors: H. Grut, S. Solberg, T. Seierstad, M. E. Revheim, T. S. Egge, S. G. Larsen et al.
Notes: Immunosuppression may not accelerate growth
Meta‐analysis of outcomes following resection of the primary tumour in patients presenting with metastatic colorectal cancer.
Authors: U. Nitsche, C. Stöß, L. Stecher, D. Wilhelm, H. Friess, G. O. Ceyhan et al.
Notes: Selected patients only
Population‐based study of factors predicting treatment intention in patients with locally recurrent rectal cancer. BJS 2017; 104: 1866-1873.
Authors: K. Westberg, G. Palmer, F. Hjern, C. Nordenvall, H. Johansson, T. Holm et al.
Notes: Defines good selection criteria
Outcome after restorative proctocolectomy and ileal pouch–anal anastomosis in children and adults. BJS 2017; 104: 1640-1647.
Authors: K. Diederen, S. S. Sahami, M. M. Tabbers, M. A. Benninga, A. Kindermann, P. J. Tanis et al.
Notes: Comparable in children and adults